These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 37448340)

  • 21. A Randomized Open label Phase-II Clinical Trial with or without Infusion of Plasma from Subjects after Convalescence of SARS-CoV-2 Infection in High-Risk Patients with Confirmed Severe SARS-CoV-2 Disease (RECOVER): A structured summary of a study protocol for a randomised controlled trial.
    Janssen M; Schäkel U; Djuka Fokou C; Krisam J; Stermann J; Kriegsmann K; Haberbosch I; Novotny JP; Weber S; Vehreschild M; Bornhäuser M; Bullinger L; Schmitt M; Liebregts T; Dreger P; Lorenz HM; Plaszczyca A; Bartenschlager R; Müller B; Kräusslich HG; Halama N; Jäger D; Schlenk RF; Leo A; Meuer S; Weigand MA; Motsch J; Merle U; Denkinger CM; Müller-Tidow C
    Trials; 2020 Oct; 21(1):828. PubMed ID: 33023671
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical signs of possible serious infection and associated mortality among young infants presenting at first-level health facilities.
    Nisar YB; Tshefu A; Longombe AL; Esamai F; Marete I; Ayede AI; Adejuyigbe EA; Wammanda RD; Qazi SA; Bahl R
    PLoS One; 2021; 16(6):e0253110. PubMed ID: 34191832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Subcutaneous Sarilumab in hospitalised patients with moderate-severe COVID-19 infection compared to the standard of care (SARCOVID): a structured summary of a study protocol for a randomised controlled trial.
    Garcia-Vicuña R; Abad-Santos F; González-Alvaro I; Ramos-Lima F; Sanz JS
    Trials; 2020 Sep; 21(1):772. PubMed ID: 32907638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluating the efficacy of a multistrain probiotic supplementation for prevention of neonatal sepsis in 0-2-month-old low birth weight infants in India-the "ProSPoNS" Study protocol for a phase III, multicentric, randomized, double-blind, placebo-controlled trial.
    Sinha AP; Gupta SS; Poluru R; Raut AV; Arora NK; Pandey RM; Sahu AR; Bethou A; Sazawal S; Parida S; Bavdekar A; Saili A; Gaind R; Kapil A; Garg BS; Maliye C; Jain M; Mahajan KS; Dhingra P; Pradhan KC; Kawade AS; Nangia S; Mukherjee A; Rasaily R; Sharma RS;
    Trials; 2021 Apr; 22(1):242. PubMed ID: 33794969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of the WHO guideline on treatment of young infants with signs of possible serious bacterial infection when hospital referral is not feasible in rural Zaria, Nigeria: Challenges and solutions.
    Wammanda RD; Adamu SA; Joshua HD; Nisar YB; Qazi SA; Aboubaker S; Bahl R
    PLoS One; 2020; 15(3):e0228718. PubMed ID: 32155155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral and immunomodulatory interferon-beta in high-risk COVID-19 patients: a structured summary of a study protocol for a randomised controlled trial.
    Aricò E; Castiello L; Bracci L; Urbani F; Lombardo F; Bacigalupo I; Ancidoni A; Vanacore N; Falcione A; Reggiani C; Dutti GM; Maglie MG; Papa O; Bartoletti PL; Ozzella G; Bevilacqua N; Nicastri E; Belardelli F; Sconocchia G
    Trials; 2021 Sep; 22(1):584. PubMed ID: 34479601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment of fast breathing in neonates and young infants with oral amoxicillin compared with penicillin-gentamicin combination: study protocol for a randomized, open-label equivalence trial.
    AFRIcan NEonatal Sepsis Trial Group
    Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S33-8. PubMed ID: 23945574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.
    Dioh W; Chabane M; Tourette C; Azbekyan A; Morelot-Panzini C; Hajjar LA; Lins M; Nair GB; Whitehouse T; Mariani J; Latil M; Camelo S; Lafont R; Dilda PJ; Veillet S; Agus S
    Trials; 2021 Jan; 22(1):42. PubMed ID: 33430924
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: a structured summary of a study protocol for a randomised controlled trial.
    Vergis N; Phillips R; Cornelius V; Katsarou A; Youngstein T; Cook L; Willicombe M; Pilay C; Shturova T; Almonte M; Charania A; Turner R; Kon OM; Cooke G; Thursz M; Cherlin S; Wason J; Milojkovic D; Innes AJ; Cooper N
    Trials; 2021 Apr; 22(1):270. PubMed ID: 33845867
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The future of Cochrane Neonatal.
    Soll RF; Ovelman C; McGuire W
    Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect on Neonatal Mortality of Newborn Infection Management at Health Posts When Referral Is Not Possible: A Cluster-Randomized Trial in Rural Ethiopia.
    Degefie Hailegebriel T; Mulligan B; Cousens S; Mathewos B; Wall S; Bekele A; Russell J; Sitrin D; Tensou B; Lawn J; de Graft Johnson J; Legesse H; Hailu S; Nigussie A; Worku B; Baqui A
    Glob Health Sci Pract; 2017 Jun; 5(2):202-216. PubMed ID: 28611102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Simplified antibiotic regimens for the management of clinically diagnosed severe infections in newborns and young infants in first-level facilities in Karachi, Pakistan: study design for an outpatient randomized controlled equivalence trial.
    Zaidi AK; Tikmani SS; Sultana S; Baloch B; Kazi M; Rehman H; Karimi K; Jehan F; Ahmed I; Cousens S
    Pediatr Infect Dis J; 2013 Sep; 32 Suppl 1(Suppl 1 Innovative Treatment Regimens for Severe Infections in Young Infants):S19-25. PubMed ID: 23945571
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Feasibility of implementing the World Health Organization case management guideline for possible serious bacterial infection among young infants in Ntcheu district, Malawi.
    Guenther T; Mopiwa G; Nsona H; Qazi S; Makuluni R; Fundani CB; Gomezgani J; Mgalula L; Chisema M; Sadruddin S
    PLoS One; 2020; 15(4):e0229248. PubMed ID: 32287262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of clinical signs of possible serious bacterial infection and mortality associated with them from population-based surveillance of young infants from birth to 2 months of age.
    Puri D; Nisar YB; Tshefu A; Longombe AL; Esamai F; Marete I; Ayede AI; Adejuyigbe EA; Wammanda RD; Qazi SA; Bahl R
    PLoS One; 2021; 16(2):e0247457. PubMed ID: 33626090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of Renin-Angiotensin-Aldosterone System blockade in patients admitted to hospital with confirmed coronavirus disease (COVID-19) infection (The McGill RAAS-COVID- 19): A structured summary of a study protocol for a randomized controlled trial.
    Aflaki M; Flannery A; Ferreira JP; Cheng MP; Kronfli N; Marelli A; Zannad F; Brophy J; Afillalo J; Huynh T; Giannetti N; Bessissow A; Ezekowitz JA; Lopes RD; Ambrosy AP; Craig M; Sharma A
    Trials; 2021 Feb; 22(1):115. PubMed ID: 33546734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothermia for moderate or severe neonatal encephalopathy in low-income and middle-income countries (HELIX): a randomised controlled trial in India, Sri Lanka, and Bangladesh.
    Thayyil S; Pant S; Montaldo P; Shukla D; Oliveira V; Ivain P; Bassett P; Swamy R; Mendoza J; Moreno-Morales M; Lally PJ; Benakappa N; Bandiya P; Shivarudhrappa I; Somanna J; Kantharajanna UB; Rajvanshi A; Krishnappa S; Joby PK; Jayaraman K; Chandramohan R; Kamalarathnam CN; Sebastian M; Tamilselvam IA; Rajendran UD; Soundrarajan R; Kumar V; Sudarsanan H; Vadakepat P; Gopalan K; Sundaram M; Seeralar A; Vinayagam P; Sajjid M; Baburaj M; Murugan KD; Sathyanathan BP; Kumaran ES; Mondkar J; Manerkar S; Joshi AR; Dewang K; Bhisikar SM; Kalamdani P; Bichkar V; Patra S; Jiwnani K; Shahidullah M; Moni SC; Jahan I; Mannan MA; Dey SK; Nahar MN; Islam MN; Shabuj KH; Rodrigo R; Sumanasena S; Abayabandara-Herath T; Chathurangika GK; Wanigasinghe J; Sujatha R; Saraswathy S; Rahul A; Radha SJ; Sarojam MK; Krishnan V; Nair MK; Devadas S; Chandriah S; Venkateswaran H; Burgod C; Chandrasekaran M; Atreja G; Muraleedharan P; Herberg JA; Kling Chong WK; Sebire NJ; Pressler R; Ramji S; Shankaran S;
    Lancet Glob Health; 2021 Sep; 9(9):e1273-e1285. PubMed ID: 34358491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A randomised, double-blind, placebo-controlled, pilot trial of intravenous plasma purified alpha-1 antitrypsin for SARS-CoV-2-induced Acute Respiratory Distress Syndrome: a structured summary of a study protocol for a randomised, controlled trial.
    McEvoy NL; Clarke JL; Mc Elvaney OJ; Mc Elvaney OF; Boland F; Hyland D; Geoghegan P; Donnelly K; Friel O; Cullen A; Collins AM; Fraughen D; Martin-Loeches I; Hennessy M; Laffey JG; Mc Elvaney NG; Curley GF
    Trials; 2021 Apr; 22(1):288. PubMed ID: 33874981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Home Treatment of Older People with Symptomatic SARS-CoV-2 Infection (COVID-19): A structured Summary of a Study Protocol for a Multi-Arm Multi-Stage (MAMS) Randomized Trial to Evaluate the Efficacy and Tolerability of Several Experimental Treatments to Reduce the Risk of Hospitalisation or Death in outpatients aged 65 years or older (COVERAGE trial).
    Duvignaud A; Lhomme E; Pistone T; Onaisi R; Sitta R; Journot V; Nguyen D; Peiffer-Smadja N; Crémer A; Bouchet S; Darnaud T; Poitrenaud D; Piroth L; Binquet C; Michel JF; Lefèvre B; Lebeaux D; Lebel J; Dupouy J; Roussillon C; Gimbert A; Wittkop L; Thiébaut R; Orne-Gliemann J; Joseph JP; Richert L; Anglaret X; Malvy D;
    Trials; 2020 Oct; 21(1):846. PubMed ID: 33050924
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.